UK Zero Rates Free NHS and Clinical Trial Medicines
Key Points
- UK government publishes VAT Notice 1004 detailing zero-rating rules for free medicines.
- Pharmaceutical firms must obtain specific certificates to qualify for the tax exemption.
- Pre-June 2026 supplies remain subject to the standard 20 percent VAT rate.
Editorial Deep Dive & Context
The UK government has published VAT Notice 1004, clarifying the conditions under which medicinal products can be zero-rated for Value Added Tax purposes. This regulatory update specifically targets medicines supplied free of charge for National Health Service (NHS) treatment, investigational products used in clinical trials, and continued treatment for patients who participated in those trials.
The notice provides detailed guidance for pharmaceutical companies, sponsors, and distributors involved in these supply chains. The new zero-rating regime officially takes effect on 23 June 2026.
Any deemed supplies occurring prior to this date remain subject to the standard VAT rate of 20%. The legal basis for this change is found in Schedule 8, Group 12, Items 1ZA to 1ZC of the VAT Act 1994. The notice outlines specific requirements for certificates needed to qualify for the zero rate and defines what constitutes a qualifying medicinal product under the law. This policy directly impacts entities participating in the Early Access to Medicines Scheme and managed access programmes across England, Wales, Scotland, and Northern Ireland. By removing VAT liabilities on free-of-charge supplies, the regulation aims to streamline funding mechanisms for critical treatments and clinical research.
Live Updates & Related Coverage (1)
Chronological updates and connected stories across this news arc. Tap any item to explore.
UK Zero Rates Free NHS and Clinical Trial Medicines
VAT Notice 1004 establishes a zero-rate for free NHS and clinical trial medicines effective from 23 June 2026